Using their trading system, Zack's experts give you their prediction for S in free RPT. Should you pass or buy SentinelOne? Zacks experts tell all in a new free Special Report.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- Top EV Stocks to Buy Now
Search results
Undervalued
- According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued.
www.tipranks.com/stocks/hrtx
People also ask
What is the cost of Heron Therapeutics (HRTX)?
What was Heron Therapeutics' stock price in 2024?
Is Heron Therapeutics a good investment?
When did Heron Therapeutics (hrtx) announce earnings results?
Where can I buy hrtx stock?
How did Heron Therapeutics perform in 2023?
Potentially undervalued companies in the Pharmaceuticals-biotech industry. Research Heron Therapeutics' (Nasdaq:HRTX) stock key valuation metrics while comparing it with its industry peers & market side by side.
Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.
- 274.52M
- 136.36M
- 48.13M
- 151.67M
Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
3 days ago · HRTX has an Altman Z-Score of -10.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Heron Therapeutics, Inc. (HRTX) stock, including valuation metrics, financial numbers, share information and more.
According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium Does Heron Therapeutics pay dividends?
- (8)
Real time Heron Therapeutics (HRTX) stock price quote, stock graph, news & analysis.
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024. (PR Newswire) -7.33%. Oct-10-24 04:08PM. Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI, SUSTOL, and APONVIE as Alternatives During the Potential Shortage of Intravenous Fluids.
%20undervalued%20stocks&ck=0163350816275ACED7512ABCC5C7D67B&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued stocks1")
%20undervalued%20stocks&ck=1DEB06445E14643BE734EA62E38E9D8E&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued stocks2")
%20undervalued%20stocks&ck=913321CDA9164D5F9D5E4F556E5F882D&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued stocks3")
%20undervalued%20stocks&ck=6200AA32B91BC8F60E9A31228EE8DBC7&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued stocks4")
%20undervalued%20stocks&ck=8B4E8E47764B3A4377A558D821DE8B88&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued stocks5")
